BACKGROUND: Development of pretransplantation islet culture strategies that preserve or enhance β-cell viability would eliminate the requirement for the large numbers of islets needed to restore insulin independence in type 1 diabetes patients. We investigated whether glial cell line-derived neurotrophic factor (GDNF) could improve human islet survival and posttransplantation function in diabetic mice. METHODS: Human islets were cultured in medium supplemented with or without GDNF (100 ng/mL) and in vitro islet survival and function assessed by analyzing β-cell apoptosis and glucose stimulated insulin release. In vivo effects of GDNF were assessed in streptozotocin-induced diabetic nude mice transplanted under the kidney capsule with 2000 islet equivalents of human islets precultured in medium supplemented with or without GDNF. RESULTS: In vitro, human islets cultured for 2 to 10 days in medium supplemented with GDNF showed lower β-cell death, increased Akt phosphorylation, and higher glucose-induced insulin secretion than islets cultured in vehicle. Human islets precultured in medium supplemented with GDNF restored more diabetic mice to normoglycemia and for a longer period after transplantation than islets cultured in vehicle. CONCLUSIONS: Our study shows that GDNF has beneficial effects on human islet survival and could be used to improve islet posttransplantation survival.
BACKGROUND: Development of pretransplantation islet culture strategies that preserve or enhance β-cell viability would eliminate the requirement for the large numbers of islets needed to restore insulin independence in type 1 diabetespatients. We investigated whether glial cell line-derived neurotrophic factor (GDNF) could improve human islet survival and posttransplantation function in diabeticmice. METHODS:Human islets were cultured in medium supplemented with or without GDNF (100 ng/mL) and in vitro islet survival and function assessed by analyzing β-cell apoptosis and glucose stimulated insulin release. In vivo effects of GDNF were assessed in streptozotocin-induced diabeticnude mice transplanted under the kidney capsule with 2000 islet equivalents of human islets precultured in medium supplemented with or without GDNF. RESULTS: In vitro, human islets cultured for 2 to 10 days in medium supplemented with GDNF showed lower β-cell death, increased Akt phosphorylation, and higher glucose-induced insulin secretion than islets cultured in vehicle. Human islets precultured in medium supplemented with GDNF restored more diabeticmice to normoglycemia and for a longer period after transplantation than islets cultured in vehicle. CONCLUSIONS: Our study shows that GDNF has beneficial effects on human islet survival and could be used to improve islet posttransplantation survival.
Authors: Bernhard J Hering; Raja Kandaswamy; Jeffrey D Ansite; Peter M Eckman; Masahiko Nakano; Toshiya Sawada; Ippei Matsumoto; Sung-Hee Ihm; Hui-Jian Zhang; Jamen Parkey; David W Hunter; David E R Sutherland Journal: JAMA Date: 2005-02-16 Impact factor: 56.272
Authors: J Carter; S Karmiol; M Nagy; R McElreath; C Calloway; A Motley; A Neill; H J Jang; A Posselt; P Stock Journal: Transplant Proc Date: 2005-10 Impact factor: 1.066
Authors: D W Scharp; P E Lacy; J V Santiago; C S McCullough; L G Weide; L Falqui; P Marchetti; R L Gingerich; A S Jaffe; P E Cryer Journal: Diabetes Date: 1990-04 Impact factor: 9.461
Authors: Tatiana Froud; Camillo Ricordi; David A Baidal; Muhammad M Hafiz; Gaston Ponte; Pablo Cure; Antonello Pileggi; Raffaella Poggioli; Hirohito Ichii; Aisha Khan; Jacqueline V Ferreira; Alberto Pugliese; Violet V Esquenazi; Norma S Kenyon; Rodolfo Alejandro Journal: Am J Transplant Date: 2005-08 Impact factor: 8.086
Authors: A M Shapiro; J R Lakey; E A Ryan; G S Korbutt; E Toth; G L Warnock; N M Kneteman; R V Rajotte Journal: N Engl J Med Date: 2000-07-27 Impact factor: 91.245
Authors: Gang Miao; John Mace; Michael Kirby; Andrew Hopper; Ricardo Peverini; Richard Chinnock; James Shapiro; Eba Hathout Journal: Transplantation Date: 2006-02-27 Impact factor: 4.939
Authors: Philip J O'Connell; Wayne J Hawthorne; D Jane Holmes-Walker; Brian J Nankivell; Jenny E Gunton; Anita T Patel; Stacey N Walters; Henry C C Pleass; Richard D M Allen; Jeremy R Chapman Journal: Med J Aust Date: 2006-03-06 Impact factor: 7.738
Authors: Susan M Mitchell; Jason P Ross; Horace R Drew; Thu Ho; Glenn S Brown; Neil F W Saunders; Konsta R Duesing; Michael J Buckley; Rob Dunne; Iain Beetson; Keith N Rand; Aidan McEvoy; Melissa L Thomas; Rohan T Baker; David A Wattchow; Graeme P Young; Trevor J Lockett; Susanne K Pedersen; Lawrence C Lapointe; Peter L Molloy Journal: BMC Cancer Date: 2014-01-31 Impact factor: 4.430
Authors: Anja Brboric; Svitlana Vasylovska; Jonna Saarimäki-Vire; Daniel Espes; José Caballero-Corbalan; Gunnar Larfors; Timo Otonkoski; Joey Lau Journal: Ups J Med Sci Date: 2019-10-18 Impact factor: 2.384